RxDoctor Payments Data

James Bresch, MD

Orthopaedic Surgery · Park Ridge, ILNPI 1639279110

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 97.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $32,572 and has fallen 99.8% since, to $59 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,797in general payments, 2019–2025

Across 73 payments — averaging $1065.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$76K
  • Catalyst Orthoscience$2K
  • Innovation Technologies Inc$171
  • Stryker$73
  • Ferring Pharmaceuticals Inc.$73
  • Orthosensor Inc.$18
  • plus $14 from 1 others
$45,840in research payments, 2019–2025

Across 26 payments — averaging $1763.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$46K

What the payments were for

  • Consulting fees$25,49833%
  • Speaking & faculty fees$41,26353%
  • Travel & lodging$8,57411%
  • Food & beverage$2,4623%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,797 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$350,329
Medicare patients
529
Services billed
15,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib39$780
Diclofenac Sodium14$217
Amoxicillin30$30
Cephalexin12$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Park Ridge

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →